HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Pfizer Inc. (PFE)
38.18  0.75  (2%) 10-25 12:30
Open: 37.93 High: 38.285
Pre.close: 37.43 Low: 37.6474
Volume: 25,230,908 Ave vol: 23,126,742
52w High: 40.97 52w Low: 27.88
MA(50): 36.654 MA(200): 36.571
EPS: 2.526 P/E Ratio: 15.11
Company profile
Exchange: NYSE
Sector: Healthcare
Industry: Drug Manufacturers General
Website: https://www.pfizer.com/
Market Cap (M): 212,162
Shares Out (M): 5,557
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. The company is headquartered in New York City, New York and currently employs 92,400 full-time employees. The firm is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The firm manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.
Technical analysis
Overall: Outperform
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bullish
Target 1: 45.38 Target 2: 53.00
Resist 1: 38.85 Resist 2: 45.38
Support 1: 36.71 Support 2: 35.38
Company key metrics
Revenue per Share: 0
Net Income per Share: 0
Cash per Share: 0
Book Value per Share: 0
Price to Sales: 0
Price to Book Value: 0
Earnings Yield: 0
Dividend Yield: 0
Debt to Equity: 1.6525
Debt to Assets: 0.623
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Outperform
Debt to Equity: Outperform
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.